Premium
A proteomics analysis reveals that A2M might be regulated by STAT 3 in persistent allergic rhinitis
Author(s) -
Chen X.,
Xie Z. H.,
Lv Y. X.,
Tang Q. P.,
Zhang H.,
Zhang J. Y.,
Wu B.,
Jiang W. H.
Publication year - 2016
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/cea.12711
Subject(s) - proteomics , stat , immunofluorescence , biology , quantitative proteomics , immunology , microbiology and biotechnology , signal transduction , antibody , gene , genetics , stat3
Summary Background Proteomics tools can be used to identify the differentially expressed proteins related to allergic rhinitis ( AR ). However, the large numbers of proteins related to AR have not yet been explored using an advanced quantitative proteomics approach, known as isobaric tags for relative and absolute quantitation ( iTRAQ ). Objectives To identify differentially expressed proteins in persistent AR patients and to explore the regulatory signalling pathways involving the identified proteins. Methods Forty‐five persistent AR patients and 20 healthy controls were recruited for this study. iTRAQ was used to identify the proteins that were differentially expressed between these two groups, and a bioinformatics analysis was then conducted to identify the signalling pathways associated with the identified proteins. Immunofluorescence labelling was performed to detect alpha‐2‐macroglobulin (A2M), STAT 3, p‐ STAT 3 and IL 17 in the nasal mucosa. Results A total of 133 differentially expressed proteins were identified. We then determined the top 10 regulatory pathways associated with these proteins and found that the blood coagulation pathway had the most significant association. A2M, a protein involved in the blood coagulation pathway, was found to be differentially expressed in the serum of AR patients. The bioinformatics analysis indicated that STAT 3 is an upstream transcription factor that might regulate A2M expression. An immunofluorescence study further confirmed that STAT 3 and A2M are co‐localized in nasal mucosa cells. Additionally, A2M, STAT 3, p‐ STAT 3, and IL 17 are elevated in AR patients. The expressional level of A2M is positively related to IL 17 and the symptom of the congestion in AR subjects. Conclusions The blood coagulation pathway may be a key regulatory network pathway contributing to the allergic inflammatory response in AR patients. A2M, which is regulated by STAT 3, may be an important protein in the pathogenesis of allergic rhinitis in AR patients.